Hepatopulmonary syndrome following portopulmonary hypertension

European Respiratory Journal

Volumn 29, Issue 6, 2007, Pages 1277-1280

  Ioachimescu, O C ^a   Mehta, A C ^a   Stoller, J K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiopulmonary pathophysiology; Cardiorespiratory; Hepatopulmonary problems; Hepatopulmonary syndrome; Pulmonary circulation physiopathology; Pulmonary hypertension

Indexed keywords

OXYGEN;

AGED; ANAMNESIS; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEART CATHETERIZATION; HEPATITIS C; HEPATOPULMONARY SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; LIVER CIRRHOSIS; MALE; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; SPIROMETRY;

AGED; BLOOD GAS ANALYSIS; ECHOCARDIOGRAPHY; FIBROSIS; HEPATITIS C; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER DISEASES; MALE; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 34250189526     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00140306     Document Type: Article

References (23)

1. Shah TJ, Isaac J, Adams D, Kelly D. Development of hepatopulmonary syndrome and portopulmonary hypertension in a paediatric liver transplant patient. Pediatr Transplant 2005; 9: 127-131.
2. Martinez-Palli G, Barbera JA, Taura P, Cirera I, Visa J, Rodriguez-Roisin R. Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome. J Hepatol 1999; 31: 1075-1079.
3. Jones FD, Kuo PC, Johnson LB, Njoku MJ, Dixon-Ferguson MK, Plotkin JS. The coexistence of portopulmonary hypertension and hepatopulmonary syndrome. Anesthesiology 1999; 90: 626-629.
4. Mal H, Burgiere O, Durand F, Fartoukh M, Cohen-Solal A, Fournier M. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis. J Hepatol 1999; 31: 360-364.
5. Kaspar MD, Ramsay MA, Shuey CB, Levy MF Jr, Klintmahn GG. Severe pulmonary hypertension and amelioration of hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 1998; 4: 177-179.
6. Tasaka S, Kanazawa M, Nakamura H, et al. [An autopsied case of primary pulmonary hypertension complicated by hepatopulmonary syndrome.] Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33: 90-94.
7. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 1998; 27: 232-235.
8. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 1979; 120: 849-856.
9. Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996; 17: 17-33.
10. Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67: 737-744.
11. Morse JH, Deng Z, Knowles JA. Genetic aspects of pulmonary arterial hypertension. Ann Med 2001; 33: 596-603.
12. Egermayer P, Town GI, Peacock AJ. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 1999; 54: 161-168.
13. Panos RJ, Baker SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med 1996; 17: 151-169.
14. Maruyama T, Ohsaki K, Shimoda S, Kaji Y, Harada M. Thromboxane-dependent portopulmonary hypertension. Am J Med 2005; 118: 93-94.
15. Rolla G. Hepatopulmonary syndrome: role of nitric oxide and clinical aspects. Dig Liver Dis 2004; 36: 303-308.
16. Nunes H, Lebrec D, Mazmanian M, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001; 164: 879-885.
17. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113: 606-614.
18. Cremona G, Higenbottam TW, Mayoral V, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-1885.
19. Schenk P, Madl C, Rezaie-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000; 133: 701-706.
20. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521-529.
21. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, ERS Task Force Puhnonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861-880.
22. Gómez FP, Barbera JA, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R. Effects of nebulized N(G)-nitro-L- arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology2006; 20: 1084-1091.
23. Fallon MB. Hepatopulmonary syndrome: more than just a matter of tone? Hepatology 2006; 43: 912-913.